# Prevalence and distribution of low and high myopia in Mexican outpatients: a nationwide cross-sectional clinic-based study

**Authors:** José Antonio Magaña-Lizárraga, Abraham García-Gil, José Manuel Romero-Flores, Eduardo Espinoza-Angulo, Héctor Machado-Jiménez, Marco Antonio Luna-Ruiz-Esparza, Humberto Gómez-Campaña, Leticia Riverón-Negrete, Linda Nasser-Nasser, Abraham Campos-Romero, Jonathan Alcántar-Fernández

PMC · DOI: 10.3389/fmed.2026.1753396 · Frontiers in Medicine · 2026-02-23

## TL;DR

This study estimates the prevalence of low and high myopia in Mexico using nationwide clinic data, finding higher rates in females and younger age groups.

## Contribution

The study provides the first recent nationwide data on myopia prevalence in Mexico, including insights into high myopia post-COVID-19.

## Key findings

- Low myopia was more common in males, while high myopia was more prevalent in females.
- Astigmatism significantly increased the risk of both low and high myopia.
- The Central region of Mexico had the highest prevalence of both types of myopia.

## Abstract

Myopia is a global public health concern and a leading cause of distance vision impairment, affecting mainly children and young adults. Although several studies have reported myopia prevalence in Mexico, recent nationwide data, especially regarding high myopia, are lacking following the COVID-19 pandemic. We estimated the prevalence and distribution of low and high myopia in a cohort of Mexican outpatients.

A retrospective, cross-sectional, clinic-based study was conducted using anonymized electronic health records from Salud Digna clinics. Data included individuals aged 6–100 years undergoing routine non-cycloplegic eye examinations between January and December 2023. Myopia was defined as spherical equivalent refraction (SER) ≤ −0.50 diopters (D) in the right eye and subclassified into low (−6.0 D < SER ≤ −0.50 D) or high (SER ≤ −6.0 D). Age-standardized prevalence rates were estimated overall and by sex and geographic location. Multinomial logistic regression evaluated potential risk between demographic/clinical background and myopia severity.

From 3,507,826 records, 1,337,526 (38.13%) individuals were myopic (median age: 28 years; 61.4% females). Age-standardized rates for total, low, and high myopia were 44.44% (95% CI, 44.36–44.52%), 43.31% (95% CI, 43.24–43.39%), and 1.12% (95% CI, 1.11–1.14%), respectively. Low myopia was more prevalent in males, whereas high myopia predominated in females (both p < 0.001). Both forms were most prevalent in individuals ≤ 10 through 31–40 years, peaking at 64.65 and 1.75% in the 21–30 age group. The Central region, specifically Mexico City, State of Mexico, Puebla, and Tlaxcala, had the highest prevalence of low and high myopia. Mild, moderate, and severe astigmatism significantly increased the myopia risk: 3-, 8-, and 11-fold for low myopia and 5-, 33-, and 100-fold for high myopia (all p < 0.001). Male sex, diabetes, and high blood pressure were associated with a lower risk (all p < 0.001).

Astigmatism was a risk factor for myopia, with increasing severity raising the risk of developing both forms of myopia. Although high myopia remains relatively uncommon nationally, its increasing prevalence from childhood to early adulthood highlights the need for early detection and close monitoring to mitigate future visual impairment in Mexico.

## Linked entities

- **Diseases:** myopia (MONDO:0001384), diabetes (MONDO:0005015), high blood pressure (MONDO:0005044)

## Full-text entities

- **Diseases:** blindness (MESH:D001766), retinal detachment (MESH:D012163), open-angle glaucoma (MESH:D005902), Refractive errors (MESH:D012030), glaucoma (MESH:D005901), hypertensive retinopathy (MESH:D058437), cataracts (MESH:D002386), Astigmatism (MESH:D001251), age-related macular degeneration (MESH:D008268), Low myopia (MESH:D009216), retinal degeneration (MESH:D012162), diabetic retinopathy (MESH:D003930), Diabetes (MESH:D003920), COVID (MESH:D000086382), blurred vision (MESH:D014786), condition (MESH:D020763), ocular trauma (MESH:D014947)
- **Chemicals:** luteinizing hormone (MESH:D007986), follicle stimulating hormone (MESH:D005640), Campeche (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967929/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12967929/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12967929/full.md

---
Source: https://tomesphere.com/paper/PMC12967929